An internationally respected expert in physical and psychological symptoms, Dr. Kurt Kroenke’s principal research interests include pain, depression, anxiety and other symptoms without discernible cause. He has developed multiple patient-reported outcome measures that have been translated into 80 languages, including the PHQ-9 depression scale, GAD-7 anxiety scale, PHQ-15 somatization scale, PEG pain scale, and P4 suicidality screener. The PHQ-9 and GAD-7 are now used as national guidelines, in electronic health records, and in scores of research and clinical practice settings.
Dr. Kroenke’s recently research has focused on chronic pain, one of the most common problems seen in primary care. His work examines the impact of treating depression on pain, assesses stepped care to optimize pain care effectiveness, tests novel methods to reduce race and socio-economic disparities in pain care and evaluates telecare management of chronic musculoskeletal pain.
Dr. Kroenke is appointed to the Psychological Health Subcommittee Health Board at the U.S. Department of Defense. In 2018, he received the Society of General Internal Medicine’s highest award, the Robert J. Glaser award. He has mentored more than 35 fellows and junior faculty and has more than 300 peer-reviewed research publications.